Halozyme Therapeutics, Inc.
NASDAQHalozyme Therapeutics delivered a jolt to the market this week — a 23% single-day move on August 7 following strong Q2 results, leaving a meaningful short position scrambling and analysts rushing to lift targets against a stock that has now gained 25% on the week and 26% over the past month. The short side was positioned for a different outcome. Short interest had been quietly…
Snapshot as of 8 Aug 2026
Halozyme Therapeutics delivered a jolt to the market this week — a 23% single-day move on August 7 following strong Q2 results, leaving a meaningful short position scrambling and analysts rushing to lift targets…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HALO — free to start on ORTEX.
Sign up for free →Open HALO on ORTEX